Insecticides (India)（INSECTICID）株式概要Insecticides (India) Limited は、インド国内および海外で農業用化学薬品および農薬製品の製造・販売を行っている。 詳細INSECTICID ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績2/6財務の健全性5/6配当金2/6報酬株価収益率（ 14.7 x） Indian市場（ 23 x）を下回っています。リスク分析リスクチェックの結果、INSECTICID 、リスクは検出されなかった。すべてのリスクチェックを見るINSECTICID Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹707.4526.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture031b2016201920222025202620282031Revenue ₹31.2bEarnings ₹2.0bAdvancedSet Fair ValueView all narrativesInsecticides (India) Limited 競合他社GSP Crop ScienceSymbol: NSEI:GSPCROPMarket cap: ₹20.0bBharat RasayanSymbol: NSEI:BHARATRASMarket cap: ₹23.0bIndia PesticidesSymbol: NSEI:IPLMarket cap: ₹18.4bBhagiradha Chemicals & IndustriesSymbol: BSE:531719Market cap: ₹34.7b価格と性能株価の高値、安値、推移の概要Insecticides (India)過去の株価現在の株価₹707.4552週高値₹1,098.0052週安値₹518.60ベータ0.381ヶ月の変化-1.51%3ヶ月変化15.98%1年変化-18.32%3年間の変化56.10%5年間の変化39.16%IPOからの変化3,698.96%最新ニュースReported Earnings • May 30Full year 2026 earnings released: EPS: ₹47.91 (vs ₹48.38 in FY 2025)Full year 2026 results: EPS: ₹47.91 (down from ₹48.38 in FY 2025). Revenue: ₹21.5b (up 7.6% from FY 2025). Net income: ₹1.39b (down 1.8% from FY 2025). Profit margin: 6.5% (down from 7.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.お知らせ • May 28+ 1 more updateInsecticides (India) Limited, Annual General Meeting, Aug 12, 2026Insecticides (India) Limited, Annual General Meeting, Aug 12, 2026, at 15:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹616, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 27% over the past three years.Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹3.60 (vs ₹5.96 in 3Q 2025)Third quarter 2026 results: EPS: ₹3.60 (down from ₹5.96 in 3Q 2025). Revenue: ₹3.85b (up 7.6% from 3Q 2025). Net income: ₹104.9m (down 40% from 3Q 2025). Profit margin: 2.7% (down from 4.9% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.分析記事 • Nov 20Investors Shouldn't Be Too Comfortable With Insecticides (India)'s (NSE:INSECTICID) EarningsInsecticides (India) Limited's ( NSE:INSECTICID ) robust earnings report didn't manage to move the market for its...New Risk • Oct 07New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 0% Dividend yield: 0.3% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.最新情報をもっと見るRecent updatesReported Earnings • May 30Full year 2026 earnings released: EPS: ₹47.91 (vs ₹48.38 in FY 2025)Full year 2026 results: EPS: ₹47.91 (down from ₹48.38 in FY 2025). Revenue: ₹21.5b (up 7.6% from FY 2025). Net income: ₹1.39b (down 1.8% from FY 2025). Profit margin: 6.5% (down from 7.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.お知らせ • May 28+ 1 more updateInsecticides (India) Limited, Annual General Meeting, Aug 12, 2026Insecticides (India) Limited, Annual General Meeting, Aug 12, 2026, at 15:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹616, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 27% over the past three years.Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹3.60 (vs ₹5.96 in 3Q 2025)Third quarter 2026 results: EPS: ₹3.60 (down from ₹5.96 in 3Q 2025). Revenue: ₹3.85b (up 7.6% from 3Q 2025). Net income: ₹104.9m (down 40% from 3Q 2025). Profit margin: 2.7% (down from 4.9% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.分析記事 • Nov 20Investors Shouldn't Be Too Comfortable With Insecticides (India)'s (NSE:INSECTICID) EarningsInsecticides (India) Limited's ( NSE:INSECTICID ) robust earnings report didn't manage to move the market for its...New Risk • Oct 07New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 0% Dividend yield: 0.3% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.分析記事 • Aug 14We Ran A Stock Scan For Earnings Growth And Insecticides (India) (NSE:INSECTICID) Passed With EaseIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Reported Earnings • Jul 17Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.38 (up from ₹34.49 in FY 2024). Revenue: ₹20.0b (up 1.7% from FY 2024). Net income: ₹1.42b (up 39% from FY 2024). Profit margin: 7.1% (up from 5.2% in FY 2024). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 4.3%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 15% per year.お知らせ • Jul 16+ 2 more updatesInsecticides (India) Limited to Report Q4, 2026 Results on May 30, 2026Insecticides (India) Limited announced that they will report Q4, 2026 results on May 30, 2026お知らせ • Jun 26Insecticides (India) Limited to Report Q1, 2026 Results on Aug 13, 2025Insecticides (India) Limited announced that they will report Q1, 2026 results on Aug 13, 2025お知らせ • May 29Insecticides (India) Limited, Annual General Meeting, Aug 12, 2025Insecticides (India) Limited, Annual General Meeting, Aug 12, 2025, at 15:00 Indian Standard Time.Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹48.38 (vs ₹34.59 in FY 2024)Full year 2025 results: EPS: ₹48.38 (up from ₹34.59 in FY 2024). Revenue: ₹20.1b (up 2.1% from FY 2024). Net income: ₹1.42b (up 39% from FY 2024). Profit margin: 7.1% (up from 5.2% in FY 2024). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • May 18Investors Aren't Buying Insecticides (India) Limited's (NSE:INSECTICID) EarningsInsecticides (India) Limited's ( NSE:INSECTICID ) price-to-earnings (or "P/E") ratio of 16.2x might make it look like a...Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹744, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 58% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,012 per share.分析記事 • Apr 18Is Insecticides (India) Limited (NSE:INSECTICID) Trading At A 32% Discount?Key Insights Using the 2 Stage Free Cash Flow to Equity, Insecticides (India) fair value estimate is ₹1,009...Reported Earnings • Feb 11Third quarter 2025 earnings released: EPS: ₹5.96 (vs ₹4.16 in 3Q 2024)Third quarter 2025 results: EPS: ₹5.96 (up from ₹4.16 in 3Q 2024). Revenue: ₹3.58b (flat on 3Q 2024). Net income: ₹173.7m (up 41% from 3Q 2024). Profit margin: 4.9% (up from 3.4% in 3Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 8% per year.分析記事 • Jan 30Insufficient Growth At Insecticides (India) Limited (NSE:INSECTICID) Hampers Share PriceWith a price-to-earnings (or "P/E") ratio of 14.1x Insecticides (India) Limited ( NSE:INSECTICID ) may be sending very...お知らせ • Jan 07Insecticides (India) Limited Launches New Revolutionary Insecticide, CentranInsecticides (India) Limited has launched, a new revolutionary Insecticide, Centran. This will be a pioneering solution for tackling stem borers in paddy. With its dual-action formula, Centran effectively controls stem bores and help the farmers to achieve healthier crops and better productivity. Paddy is the backbone of the Indian farmers. Stem borers pose a significant threat to their hard work. To address this, new age insecticide Centran has been developed by the R&D Team of Insecticides (India) Limited. Centran is a unique blend of dual active ingredients for pest control and crop nourishment. The product supports robust root development, improves tiller growth, and delivers superior yields, ensuring a higher return on investment for growers. With a strong distribution network and a legacy of empowering agriculture, IIL continues to bring impactful innovations that resonate with the needs of those who grow the nation's food.お知らせ • Nov 25Patent Office, Government of India Grants Patent for an Invention to Insecticides (India) Limited Entitled FUNGICIDAL COMPOSITIONS AND METHODS RELATED THERETOInsecticides (India) Limited announced that the Patent Office, Government of India has granted the Patent for an invention to Insecticides (India) Limited entitled FUNGICIDAL COMPOSITIONS AND METHODS RELATED THERETO for the term of 20 years from 28 June 2019 (Date of Filing).Price Target Changed • Nov 19Price target decreased by 18% to ₹917Down from ₹1,124, the current price target is an average from 2 analysts. New target price is 30% above last closing price of ₹708. Stock is up 27% over the past year. The company is forecast to post earnings per share of ₹47.06 for next year compared to ₹34.59 last year.Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: ₹20.78 (vs ₹17.95 in 2Q 2024)Second quarter 2025 results: EPS: ₹20.78 (up from ₹17.95 in 2Q 2024). Revenue: ₹6.27b (down 9.9% from 2Q 2024). Net income: ₹614.9m (up 16% from 2Q 2024). Profit margin: 9.8% (up from 7.6% in 2Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Nov 14Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹729, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 68% over the past three years.お知らせ • Oct 04Insecticides (India) Limited Launches Torry Super with SPF TechnologyInsecticides (India) Limited has launched Torry Super, a revolutionary post emergence herbicide designed to redefine weed control while ensuring crop safety. IIL continues to bring the latest technology with its latest post emergence herbicide Torry Super, leveraging SPF Technology to deliver unparalleled efficacy. Key benefits of Torry Super include faster weed control, visible results within 3-5 days of application, powerful weed control with extended residual activity for up to 15 days beyond conventional herbicides. Its unique SPF Technology enhances crop tolerance to herbicidal effects, ensuring robust plant health throughout the growing season. Ease of application is another key benefit of Torry Super. Date of Launch: October 5, 2024.お知らせ • Aug 30Insecticides (India) Limited (BSE:532851) announces an Equity Buyback for 500,000 shares, representing 1.69% for INR 500 million.Insecticides (India) Limited (BSE:532851) announces a share repurchase program. Under the program, the company will repurchase up to 500,000 shares, representing 1.69% of its issued share capital for a total of INR 500 million. The share will be repurchased at a price not exceeding INR 1,000 per share. The company announced that it has fixed September 11, 2024, as record date for the offer. As of August 30, 2024, the company has 29,597,837 shares in issue.Upcoming Dividend • Aug 16Upcoming dividend of ₹2.00 per shareEligible shareholders must have bought the stock before 23 August 2024. Payment date: 08 September 2024. Payout ratio is a comfortable 8.7% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).Price Target Changed • Aug 13Price target increased by 33% to ₹862Up from ₹646, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of ₹873. Stock is up 89% over the past year. The company is forecast to post earnings per share of ₹38.40 for next year compared to ₹34.59 last year.分析記事 • Aug 10Improved Earnings Required Before Insecticides (India) Limited (NSE:INSECTICID) Stock's 27% Jump Looks JustifiedDespite an already strong run, Insecticides (India) Limited ( NSE:INSECTICID ) shares have been powering on, with a...お知らせ • Aug 09Insecticides (India) Limited Declares Interim Dividend for the Financial Year 2024-2025, Payable on or from August 28, 2024Insecticides (India) Limited announced that at the Board of Directors of the Company at their meeting held August 9, 2024, declared an Interim Dividend of INR 2.00 per equity shares [20%] of face value of INR 10 each for financial year 2024-2025. The record date as informed for the purpose of determining for entitlement of the shareholders for the payment of Interim Dividend is 23 August, 2024 and the Interim Dividend will be paid to the shareholders, subject to deduction/withholding of applicable taxes, within the time prescribed under law. The Interim Dividend will be paid on or from August 28, 2024.Reported Earnings • Jul 23Full year 2024 earnings released: EPS: ₹34.59 (vs ₹21.36 in FY 2023)Full year 2024 results: EPS: ₹34.59 (up from ₹21.36 in FY 2023). Revenue: ₹19.7b (up 9.2% from FY 2023). Net income: ₹1.02b (up 62% from FY 2023). Profit margin: 5.2% (up from 3.5% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.お知らせ • Jul 18+ 1 more updateInsecticides (India) Limited to Report Q2, 2025 Results on Nov 14, 2024Insecticides (India) Limited announced that they will report Q2, 2025 results on Nov 14, 2024お知らせ • Jul 15Insecticides (India) Limited Announces Resignation of P. C. Pabbi, Sr. VP CommercialInsecticides (India) Limited announced resignation of P. C. Pabbi, Sr. VP Commercial. Mr. P. C. Pabbi, Sr. VP Commercial, who has attained the age of 60 years on March 22, 2021 and further on extension, superannuated and relieved from his services July 15, 2024.分析記事 • Jun 19Why Investors Shouldn't Be Surprised By Insecticides (India) Limited's (NSE:INSECTICID) Low P/EInsecticides (India) Limited's ( NSE:INSECTICID ) price-to-earnings (or "P/E") ratio of 19.4x might make it look like a...Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹609, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹418 per share.お知らせ • May 31Insecticides (India) Limited, Annual General Meeting, Aug 12, 2024Insecticides (India) Limited, Annual General Meeting, Aug 12, 2024, at 15:00 Indian Standard Time.お知らせ • May 30Insecticides (India) Limited Announces Directorate ChangesInsecticides (India) Limited announced that The Board took note of the retirement of Mr. Virjesh Kumar Gupta and Mr. Navin Shah, which will take effect on May 30, 2024, marking the completion of theirsecond term. Mr. Virjesh Kumar Gupta and Mr. Navin Shah have served as independent directors for consecutive two terms, with the present term spanning five years from May 31, 2019, to May 30, 2024.Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹34.59 (vs ₹21.36 in FY 2023)Full year 2024 results: EPS: ₹34.59 (up from ₹21.36 in FY 2023). Revenue: ₹19.8b (up 9.7% from FY 2023). Net income: ₹1.02b (up 62% from FY 2023). Profit margin: 5.2% (up from 3.5% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.Price Target Changed • Feb 29Price target increased by 12% to ₹646Up from ₹575, the current price target is an average from 3 analysts. New target price is 20% above last closing price of ₹537. Stock is up 27% over the past year. The company is forecast to post earnings per share of ₹33.50 for next year compared to ₹21.36 last year.Reported Earnings • Feb 06Third quarter 2024 earnings released: EPS: ₹4.16 (vs ₹3.16 in 3Q 2023)Third quarter 2024 results: EPS: ₹4.16 (up from ₹3.16 in 3Q 2023). Revenue: ₹3.59b (flat on 3Q 2023). Net income: ₹123.1m (up 31% from 3Q 2023). Profit margin: 3.4% (up from 2.6% in 3Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • Feb 06Now 20% undervaluedOver the last 90 days, the stock has risen 15% to ₹593. The fair value is estimated to be ₹745, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has declined by 9.8%. Revenue is forecast to grow by 23% in 2 years. Earnings are forecast to grow by 139% in the next 2 years.分析記事 • Dec 20Market Might Still Lack Some Conviction On Insecticides (India) Limited (NSE:INSECTICID) Even After 27% Share Price BoostInsecticides (India) Limited ( NSE:INSECTICID ) shares have continued their recent momentum with a 27% gain in the last...Valuation Update With 7 Day Price Move • Nov 24Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹609, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 110% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹280 per share.分析記事 • Nov 23We Think Insecticides (India) (NSE:INSECTICID) Is Taking Some Risk With Its DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Nov 03Second quarter 2024 earnings released: EPS: ₹17.95 (vs ₹15.15 in 2Q 2023)Second quarter 2024 results: EPS: ₹17.95 (up from ₹15.15 in 2Q 2023). Revenue: ₹6.96b (up 20% from 2Q 2023). Net income: ₹531.5m (up 19% from 2Q 2023). Profit margin: 7.6% (down from 7.7% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.分析記事 • Sep 17We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Insecticides (India) Limited's (NSE:INSECTICID) CEO For NowKey Insights Insecticides (India) will host its Annual General Meeting on 23rd of September Total pay for CEO Rajesh...お知らせ • Sep 02+ 1 more updateInsecticides (India) Limited to Report Q3, 2024 Results on Feb 14, 2024Insecticides (India) Limited announced that they will report Q3, 2024 results on Feb 14, 2024お知らせ • Aug 11Insecticides (India) Limited, Annual General Meeting, Sep 23, 2023Insecticides (India) Limited, Annual General Meeting, Sep 23, 2023, at 15:00 Indian Standard Time.Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹9.85 (vs ₹12.94 in 1Q 2023)First quarter 2024 results: EPS: ₹9.85 (down from ₹12.94 in 1Q 2023). Revenue: ₹6.44b (up 15% from 1Q 2023). Net income: ₹291.4m (down 24% from 1Q 2023). Profit margin: 4.5% (down from 6.8% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Aug 05These 4 Measures Indicate That Insecticides (India) (NSE:INSECTICID) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹21.36 (vs ₹36.11 in FY 2022)Full year 2023 results: EPS: ₹21.36 (down from ₹36.11 in FY 2022). Revenue: ₹18.0b (up 20% from FY 2022). Net income: ₹632.1m (down 41% from FY 2022). Profit margin: 3.5% (down from 7.1% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.Buying Opportunity • May 31Now 23% undervaluedOver the last 90 days, the stock is up 5.0%. The fair value is estimated to be ₹580, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.8% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 26% in 2 years. Earnings is forecast to grow by 45% in the next 2 years.Price Target Changed • Mar 21Price target decreased by 8.2% to ₹681Down from ₹742, the current price target is an average from 3 analysts. New target price is 43% above last closing price of ₹477. Stock is up 14% over the past year. The company posted earnings per share of ₹36.11 last year.分析記事 • Feb 25Here's Why Insecticides (India) (NSE:INSECTICID) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹470, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 63% over the past three years.Upcoming Dividend • Feb 17Upcoming dividend of ₹3.00 per share at 0.5% yieldEligible shareholders must have bought the stock before 24 February 2023. Payment date: 15 March 2023. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.6%). Lower than average of industry peers (0.8%).お知らせ • Feb 14Insecticides (India) Limited Declares an Interim Dividend for Financial Year 2022-2023, Payable on February 24, 2023Insecticides (India) Limited announced that at the board meeting held on February 13, 2023, the company declared an interim dividend of INR 3.00 per equity shares [30%] of face value of INR 10/- each for financial year 2022-2023. The record date as informed for the purpose of determining for entitlement of the shareholders for the payment of Interim Dividend is 24 day of February, 2023 and the Interim Dividend will be paid to the shareholders, subject to deduction/withholding of applicable taxes, within the time prescribed under law.Reported Earnings • Feb 14Third quarter 2023 earnings released: EPS: ₹3.16 (vs ₹2.79 in 3Q 2022)Third quarter 2023 results: EPS: ₹3.16 (up from ₹2.79 in 3Q 2022). Revenue: ₹3.57b (up 14% from 3Q 2022). Net income: ₹93.7m (up 14% from 3Q 2022). Profit margin: 2.6% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Jan 06Price target increased to ₹742Up from ₹676, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹727. Stock is up 52% over the past year. The company posted earnings per share of ₹36.11 last year.Reported Earnings • Nov 09Second quarter 2023 earnings released: EPS: ₹15.15 (vs ₹14.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹15.15 (up from ₹14.15 in 2Q 2022). Net income: ₹448.3m (up 7.1% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Sep 17We Think Some Shareholders May Hesitate To Increase Insecticides (India) Limited's (NSE:INSECTICID) CEO CompensationThe share price of Insecticides (India) Limited ( NSE:INSECTICID ) has increased significantly over the past few years...Upcoming Dividend • Sep 08Upcoming dividend of ₹3.00 per shareEligible shareholders must have bought the stock before 15 September 2022. Payment date: 23 October 2022. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.6%). Lower than average of industry peers (0.7%).お知らせ • Sep 03+ 1 more updateInsecticides (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Insecticides (India) Limited announced that they will report Q3, 2023 results on Feb 14, 2023Price Target Changed • Aug 18Price target increased to ₹925Up from ₹807, the current price target is provided by 1 analyst. New target price is 9.2% below last closing price of ₹1,019. Stock is up 35% over the past year. The company posted earnings per share of ₹54.17 last year.Reported Earnings • Aug 14First quarter 2023 earnings released: EPS: ₹19.41 (vs ₹17.37 in 1Q 2022)First quarter 2023 results: EPS: ₹19.41 (up from ₹17.37 in 1Q 2022). Revenue: ₹5.61b (up 20% from 1Q 2022). Net income: ₹383.1m (up 9.6% from 1Q 2022). Profit margin: 6.8% (down from 7.5% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Price Target Changed • Jun 02Price target increased to ₹803Up from ₹748, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of ₹788. Stock is up 43% over the past year. The company posted earnings per share of ₹54.17 last year.Reported Earnings • May 27Full year 2022 earnings released: EPS: ₹54.17 (vs ₹45.43 in FY 2021)Full year 2022 results: EPS: ₹54.17 (up from ₹45.43 in FY 2021). Revenue: ₹15.1b (up 6.2% from FY 2021). Net income: ₹1.07b (up 14% from FY 2021). Profit margin: 7.1% (up from 6.6% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. Independent Non-Executive Women Director Praveen Gupta was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹4.18 (up from ₹2.97 in 3Q 2021). Revenue: ₹3.14b (up 4.9% from 3Q 2021). Net income: ₹82.6m (up 34% from 3Q 2021). Profit margin: 2.6% (up from 2.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Reported Earnings • Nov 13Second quarter 2022 earnings released: EPS ₹21.22 (vs ₹20.13 in 2Q 2021)The company reported a mediocre second quarter result with weaker revenues, although earnings were flat and profit margins improved. Second quarter 2022 results: Revenue: ₹4.44b (down 2.7% from 2Q 2021). Net income: ₹418.8m (flat on 2Q 2021). Profit margin: 9.4% (up from 9.1% in 2Q 2021). The increase in margin was driven by lower expenses.Reported Earnings • Aug 11First quarter 2022 earnings released: EPS ₹17.37 (vs ₹11.79 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹4.68b (up 14% from 1Q 2021). Net income: ₹349.6m (up 44% from 1Q 2021). Profit margin: 7.5% (up from 5.9% in 1Q 2021). The increase in margin was driven by higher revenue.分析記事 • Aug 04Does Insecticides (India) (NSE:INSECTICID) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Jun 20Full year 2021 earnings released: EPS ₹45.43 (vs ₹42.05 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹14.3b (up 4.7% from FY 2020). Net income: ₹939.0m (up 8.0% from FY 2020). Profit margin: 6.6% (up from 6.4% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹639, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 9.1% over the past three years.分析記事 • May 25The Returns On Capital At Insecticides (India) (NSE:INSECTICID) Don't Inspire ConfidenceIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...分析記事 • May 04Here's What You Should Know About Insecticides (India) Limited's (NSE:INSECTICID) 0.4% Dividend YieldCould Insecticides (India) Limited ( NSE:INSECTICID ) be an attractive dividend share to own for the long haul...Price Target Changed • Apr 10Price target decreased to ₹529Down from ₹574, the current price target is provided by 1 analyst. New target price is 13% above last closing price of ₹468. Stock is up 35% over the past year.Is New 90 Day High Low • Mar 15New 90-day low: ₹446The company is down 5.0% from a price of ₹470 on 15 December 2020. Underperformed the Indian market, which is up 14% over the last 90 days. Lagged the Chemicals industry, which is up 9.0% over the same period.分析記事 • Mar 10We Think Insecticides (India) (NSE:INSECTICID) Can Stay On Top Of Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Feb 23The Trends At Insecticides (India) (NSE:INSECTICID) That You Should Know AboutIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...分析記事 • Feb 10If You Had Bought Insecticides (India) (NSE:INSECTICID) Shares Five Years Ago You'd Have Earned 54% ReturnsThe main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹2.97 (vs ₹4.30 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹3.00b (up 14% from 3Q 2020). Net income: ₹61.5m (down 31% from 3Q 2020). Profit margin: 2.0% (down from 3.4% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 17% per year.Is New 90 Day High Low • Feb 04New 90-day high: ₹511The company is up 11% from its price of ₹460 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.分析記事 • Jan 28Read This Before Buying Insecticides (India) Limited (NSE:INSECTICID) For Its DividendCould Insecticides (India) Limited ( NSE:INSECTICID ) be an attractive dividend share to own for the long haul...Is New 90 Day High Low • Jan 15New 90-day high: ₹510The company is up 7.0% from its price of ₹478 on 16 October 2020. The Indian market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period.分析記事 • Jan 13Here's What Insecticides (India) Limited's (NSE:INSECTICID) Shareholder Ownership Structure Looks LikeA look at the shareholders of Insecticides (India) Limited ( NSE:INSECTICID ) can tell us which group is most powerful...分析記事 • Dec 29Insecticides (India) Limited's (NSE:INSECTICID) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?With its stock down 4.9% over the past three months, it is easy to disregard Insecticides (India) (NSE:INSECTICID...分析記事 • Dec 14Here's Why We Think Insecticides (India)'s (NSE:INSECTICID) Statutory Earnings Might Be ConservativeStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. However...分析記事 • Nov 29These 4 Measures Indicate That Insecticides (India) (NSE:INSECTICID) Is Using Debt Reasonably WellDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Nov 14Should You Buy Insecticides (India) Limited (NSE:INSECTICID) For Its Upcoming Dividend?Readers hoping to buy Insecticides (India) Limited (NSE:INSECTICID) for its dividend will need to make their move...Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS ₹20.13The company reported a poor second quarter result with weaker earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₹4.61b (down 8.4% from 2Q 2020). Net income: ₹416.1m (down 15% from 2Q 2020). Profit margin: 9.0% (in line with 2Q 2020).Is New 90 Day High Low • Nov 10New 90-day low: ₹445The company is down 6.0% from its price of ₹475 on 12 August 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.分析記事 • Nov 09Insecticides (India)'s (NSE:INSECTICID) Stock Price Has Reduced 46% In The Past Three YearsMany investors define successful investing as beating the market average over the long term. But its virtually certain...分析記事 • Oct 19Returns On Capital At Insecticides (India) (NSE:INSECTICID) Paint An Interesting PictureIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...株主還元INSECTICIDIN ChemicalsIN 市場7D-2.5%0.1%-1.2%1Y-18.3%-5.5%-5.1%株主還元を見る業界別リターン: INSECTICID過去 1 年間で-5.5 % の収益を上げたIndian Chemicals業界を下回りました。リターン対市場: INSECTICIDは、過去 1 年間で-5.1 % のリターンを上げたIndian市場を下回りました。価格変動Is INSECTICID's price volatile compared to industry and market?INSECTICID volatilityINSECTICID Average Weekly Movement5.8%Chemicals Industry Average Movement7.2%Market Average Movement7.1%10% most volatile stocks in IN Market10.2%10% least volatile stocks in IN Market4.7%安定した株価: INSECTICID 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: INSECTICIDの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19961,729Rajesh Aggarwalwww.insecticidesindia.comInsecticides (India) Limited は、インド国内外で農業用化学品や農薬製品の製造・販売を行っている。殺菌剤、殺虫剤、除草剤、生物学的製剤、植物成長調整剤など、さまざまな作物保護・栄養製品を提供している。同社はトラクターのブランド名で代理店、小売店、販売店のネットワークを通じて製品を販売している。Insecticides (India) Limited は 1996 年に設立され、インドのデリーに本拠を置く。もっと見るInsecticides (India) Limited 基礎のまとめInsecticides (India) の収益と売上を時価総額と比較するとどうか。INSECTICID 基礎統計学時価総額₹20.51b収益（TTM）₹1.39b売上高(TTM)₹21.40b14.7xPER（株価収益率1.0xP/SレシオINSECTICID は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計INSECTICID 損益計算書（TTM）収益₹21.40b売上原価₹14.65b売上総利益₹6.75bその他の費用₹5.36b収益₹1.39b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）47.91グロス・マージン31.55%純利益率6.51%有利子負債／自己資本比率11.8%INSECTICID の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.3%現在の配当利回り4%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/10 07:30終値2026/06/10 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Insecticides (India) Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関null null360 ONE Capital Market Private Limitednull nullAsian Markets Securities Private LimitedNandan ChakrabortyAxis Capital Limited8 その他のアナリストを表示
Reported Earnings • May 30Full year 2026 earnings released: EPS: ₹47.91 (vs ₹48.38 in FY 2025)Full year 2026 results: EPS: ₹47.91 (down from ₹48.38 in FY 2025). Revenue: ₹21.5b (up 7.6% from FY 2025). Net income: ₹1.39b (down 1.8% from FY 2025). Profit margin: 6.5% (down from 7.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
お知らせ • May 28+ 1 more updateInsecticides (India) Limited, Annual General Meeting, Aug 12, 2026Insecticides (India) Limited, Annual General Meeting, Aug 12, 2026, at 15:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹616, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 27% over the past three years.
Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹3.60 (vs ₹5.96 in 3Q 2025)Third quarter 2026 results: EPS: ₹3.60 (down from ₹5.96 in 3Q 2025). Revenue: ₹3.85b (up 7.6% from 3Q 2025). Net income: ₹104.9m (down 40% from 3Q 2025). Profit margin: 2.7% (down from 4.9% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
分析記事 • Nov 20Investors Shouldn't Be Too Comfortable With Insecticides (India)'s (NSE:INSECTICID) EarningsInsecticides (India) Limited's ( NSE:INSECTICID ) robust earnings report didn't manage to move the market for its...
New Risk • Oct 07New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 0% Dividend yield: 0.3% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
Reported Earnings • May 30Full year 2026 earnings released: EPS: ₹47.91 (vs ₹48.38 in FY 2025)Full year 2026 results: EPS: ₹47.91 (down from ₹48.38 in FY 2025). Revenue: ₹21.5b (up 7.6% from FY 2025). Net income: ₹1.39b (down 1.8% from FY 2025). Profit margin: 6.5% (down from 7.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
お知らせ • May 28+ 1 more updateInsecticides (India) Limited, Annual General Meeting, Aug 12, 2026Insecticides (India) Limited, Annual General Meeting, Aug 12, 2026, at 15:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹616, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 27% over the past three years.
Reported Earnings • Jan 31Third quarter 2026 earnings released: EPS: ₹3.60 (vs ₹5.96 in 3Q 2025)Third quarter 2026 results: EPS: ₹3.60 (down from ₹5.96 in 3Q 2025). Revenue: ₹3.85b (up 7.6% from 3Q 2025). Net income: ₹104.9m (down 40% from 3Q 2025). Profit margin: 2.7% (down from 4.9% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
分析記事 • Nov 20Investors Shouldn't Be Too Comfortable With Insecticides (India)'s (NSE:INSECTICID) EarningsInsecticides (India) Limited's ( NSE:INSECTICID ) robust earnings report didn't manage to move the market for its...
New Risk • Oct 07New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 0% Dividend yield: 0.3% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
分析記事 • Aug 14We Ran A Stock Scan For Earnings Growth And Insecticides (India) (NSE:INSECTICID) Passed With EaseIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Reported Earnings • Jul 17Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.38 (up from ₹34.49 in FY 2024). Revenue: ₹20.0b (up 1.7% from FY 2024). Net income: ₹1.42b (up 39% from FY 2024). Profit margin: 7.1% (up from 5.2% in FY 2024). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 4.3%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 15% per year.
お知らせ • Jul 16+ 2 more updatesInsecticides (India) Limited to Report Q4, 2026 Results on May 30, 2026Insecticides (India) Limited announced that they will report Q4, 2026 results on May 30, 2026
お知らせ • Jun 26Insecticides (India) Limited to Report Q1, 2026 Results on Aug 13, 2025Insecticides (India) Limited announced that they will report Q1, 2026 results on Aug 13, 2025
お知らせ • May 29Insecticides (India) Limited, Annual General Meeting, Aug 12, 2025Insecticides (India) Limited, Annual General Meeting, Aug 12, 2025, at 15:00 Indian Standard Time.
Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹48.38 (vs ₹34.59 in FY 2024)Full year 2025 results: EPS: ₹48.38 (up from ₹34.59 in FY 2024). Revenue: ₹20.1b (up 2.1% from FY 2024). Net income: ₹1.42b (up 39% from FY 2024). Profit margin: 7.1% (up from 5.2% in FY 2024). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • May 18Investors Aren't Buying Insecticides (India) Limited's (NSE:INSECTICID) EarningsInsecticides (India) Limited's ( NSE:INSECTICID ) price-to-earnings (or "P/E") ratio of 16.2x might make it look like a...
Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹744, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 58% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,012 per share.
分析記事 • Apr 18Is Insecticides (India) Limited (NSE:INSECTICID) Trading At A 32% Discount?Key Insights Using the 2 Stage Free Cash Flow to Equity, Insecticides (India) fair value estimate is ₹1,009...
Reported Earnings • Feb 11Third quarter 2025 earnings released: EPS: ₹5.96 (vs ₹4.16 in 3Q 2024)Third quarter 2025 results: EPS: ₹5.96 (up from ₹4.16 in 3Q 2024). Revenue: ₹3.58b (flat on 3Q 2024). Net income: ₹173.7m (up 41% from 3Q 2024). Profit margin: 4.9% (up from 3.4% in 3Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 8% per year.
分析記事 • Jan 30Insufficient Growth At Insecticides (India) Limited (NSE:INSECTICID) Hampers Share PriceWith a price-to-earnings (or "P/E") ratio of 14.1x Insecticides (India) Limited ( NSE:INSECTICID ) may be sending very...
お知らせ • Jan 07Insecticides (India) Limited Launches New Revolutionary Insecticide, CentranInsecticides (India) Limited has launched, a new revolutionary Insecticide, Centran. This will be a pioneering solution for tackling stem borers in paddy. With its dual-action formula, Centran effectively controls stem bores and help the farmers to achieve healthier crops and better productivity. Paddy is the backbone of the Indian farmers. Stem borers pose a significant threat to their hard work. To address this, new age insecticide Centran has been developed by the R&D Team of Insecticides (India) Limited. Centran is a unique blend of dual active ingredients for pest control and crop nourishment. The product supports robust root development, improves tiller growth, and delivers superior yields, ensuring a higher return on investment for growers. With a strong distribution network and a legacy of empowering agriculture, IIL continues to bring impactful innovations that resonate with the needs of those who grow the nation's food.
お知らせ • Nov 25Patent Office, Government of India Grants Patent for an Invention to Insecticides (India) Limited Entitled FUNGICIDAL COMPOSITIONS AND METHODS RELATED THERETOInsecticides (India) Limited announced that the Patent Office, Government of India has granted the Patent for an invention to Insecticides (India) Limited entitled FUNGICIDAL COMPOSITIONS AND METHODS RELATED THERETO for the term of 20 years from 28 June 2019 (Date of Filing).
Price Target Changed • Nov 19Price target decreased by 18% to ₹917Down from ₹1,124, the current price target is an average from 2 analysts. New target price is 30% above last closing price of ₹708. Stock is up 27% over the past year. The company is forecast to post earnings per share of ₹47.06 for next year compared to ₹34.59 last year.
Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: ₹20.78 (vs ₹17.95 in 2Q 2024)Second quarter 2025 results: EPS: ₹20.78 (up from ₹17.95 in 2Q 2024). Revenue: ₹6.27b (down 9.9% from 2Q 2024). Net income: ₹614.9m (up 16% from 2Q 2024). Profit margin: 9.8% (up from 7.6% in 2Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹729, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 68% over the past three years.
お知らせ • Oct 04Insecticides (India) Limited Launches Torry Super with SPF TechnologyInsecticides (India) Limited has launched Torry Super, a revolutionary post emergence herbicide designed to redefine weed control while ensuring crop safety. IIL continues to bring the latest technology with its latest post emergence herbicide Torry Super, leveraging SPF Technology to deliver unparalleled efficacy. Key benefits of Torry Super include faster weed control, visible results within 3-5 days of application, powerful weed control with extended residual activity for up to 15 days beyond conventional herbicides. Its unique SPF Technology enhances crop tolerance to herbicidal effects, ensuring robust plant health throughout the growing season. Ease of application is another key benefit of Torry Super. Date of Launch: October 5, 2024.
お知らせ • Aug 30Insecticides (India) Limited (BSE:532851) announces an Equity Buyback for 500,000 shares, representing 1.69% for INR 500 million.Insecticides (India) Limited (BSE:532851) announces a share repurchase program. Under the program, the company will repurchase up to 500,000 shares, representing 1.69% of its issued share capital for a total of INR 500 million. The share will be repurchased at a price not exceeding INR 1,000 per share. The company announced that it has fixed September 11, 2024, as record date for the offer. As of August 30, 2024, the company has 29,597,837 shares in issue.
Upcoming Dividend • Aug 16Upcoming dividend of ₹2.00 per shareEligible shareholders must have bought the stock before 23 August 2024. Payment date: 08 September 2024. Payout ratio is a comfortable 8.7% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).
Price Target Changed • Aug 13Price target increased by 33% to ₹862Up from ₹646, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of ₹873. Stock is up 89% over the past year. The company is forecast to post earnings per share of ₹38.40 for next year compared to ₹34.59 last year.
分析記事 • Aug 10Improved Earnings Required Before Insecticides (India) Limited (NSE:INSECTICID) Stock's 27% Jump Looks JustifiedDespite an already strong run, Insecticides (India) Limited ( NSE:INSECTICID ) shares have been powering on, with a...
お知らせ • Aug 09Insecticides (India) Limited Declares Interim Dividend for the Financial Year 2024-2025, Payable on or from August 28, 2024Insecticides (India) Limited announced that at the Board of Directors of the Company at their meeting held August 9, 2024, declared an Interim Dividend of INR 2.00 per equity shares [20%] of face value of INR 10 each for financial year 2024-2025. The record date as informed for the purpose of determining for entitlement of the shareholders for the payment of Interim Dividend is 23 August, 2024 and the Interim Dividend will be paid to the shareholders, subject to deduction/withholding of applicable taxes, within the time prescribed under law. The Interim Dividend will be paid on or from August 28, 2024.
Reported Earnings • Jul 23Full year 2024 earnings released: EPS: ₹34.59 (vs ₹21.36 in FY 2023)Full year 2024 results: EPS: ₹34.59 (up from ₹21.36 in FY 2023). Revenue: ₹19.7b (up 9.2% from FY 2023). Net income: ₹1.02b (up 62% from FY 2023). Profit margin: 5.2% (up from 3.5% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
お知らせ • Jul 18+ 1 more updateInsecticides (India) Limited to Report Q2, 2025 Results on Nov 14, 2024Insecticides (India) Limited announced that they will report Q2, 2025 results on Nov 14, 2024
お知らせ • Jul 15Insecticides (India) Limited Announces Resignation of P. C. Pabbi, Sr. VP CommercialInsecticides (India) Limited announced resignation of P. C. Pabbi, Sr. VP Commercial. Mr. P. C. Pabbi, Sr. VP Commercial, who has attained the age of 60 years on March 22, 2021 and further on extension, superannuated and relieved from his services July 15, 2024.
分析記事 • Jun 19Why Investors Shouldn't Be Surprised By Insecticides (India) Limited's (NSE:INSECTICID) Low P/EInsecticides (India) Limited's ( NSE:INSECTICID ) price-to-earnings (or "P/E") ratio of 19.4x might make it look like a...
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹609, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹418 per share.
お知らせ • May 31Insecticides (India) Limited, Annual General Meeting, Aug 12, 2024Insecticides (India) Limited, Annual General Meeting, Aug 12, 2024, at 15:00 Indian Standard Time.
お知らせ • May 30Insecticides (India) Limited Announces Directorate ChangesInsecticides (India) Limited announced that The Board took note of the retirement of Mr. Virjesh Kumar Gupta and Mr. Navin Shah, which will take effect on May 30, 2024, marking the completion of theirsecond term. Mr. Virjesh Kumar Gupta and Mr. Navin Shah have served as independent directors for consecutive two terms, with the present term spanning five years from May 31, 2019, to May 30, 2024.
Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹34.59 (vs ₹21.36 in FY 2023)Full year 2024 results: EPS: ₹34.59 (up from ₹21.36 in FY 2023). Revenue: ₹19.8b (up 9.7% from FY 2023). Net income: ₹1.02b (up 62% from FY 2023). Profit margin: 5.2% (up from 3.5% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.
Price Target Changed • Feb 29Price target increased by 12% to ₹646Up from ₹575, the current price target is an average from 3 analysts. New target price is 20% above last closing price of ₹537. Stock is up 27% over the past year. The company is forecast to post earnings per share of ₹33.50 for next year compared to ₹21.36 last year.
Reported Earnings • Feb 06Third quarter 2024 earnings released: EPS: ₹4.16 (vs ₹3.16 in 3Q 2023)Third quarter 2024 results: EPS: ₹4.16 (up from ₹3.16 in 3Q 2023). Revenue: ₹3.59b (flat on 3Q 2023). Net income: ₹123.1m (up 31% from 3Q 2023). Profit margin: 3.4% (up from 2.6% in 3Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • Feb 06Now 20% undervaluedOver the last 90 days, the stock has risen 15% to ₹593. The fair value is estimated to be ₹745, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has declined by 9.8%. Revenue is forecast to grow by 23% in 2 years. Earnings are forecast to grow by 139% in the next 2 years.
分析記事 • Dec 20Market Might Still Lack Some Conviction On Insecticides (India) Limited (NSE:INSECTICID) Even After 27% Share Price BoostInsecticides (India) Limited ( NSE:INSECTICID ) shares have continued their recent momentum with a 27% gain in the last...
Valuation Update With 7 Day Price Move • Nov 24Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹609, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 110% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹280 per share.
分析記事 • Nov 23We Think Insecticides (India) (NSE:INSECTICID) Is Taking Some Risk With Its DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Nov 03Second quarter 2024 earnings released: EPS: ₹17.95 (vs ₹15.15 in 2Q 2023)Second quarter 2024 results: EPS: ₹17.95 (up from ₹15.15 in 2Q 2023). Revenue: ₹6.96b (up 20% from 2Q 2023). Net income: ₹531.5m (up 19% from 2Q 2023). Profit margin: 7.6% (down from 7.7% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
分析記事 • Sep 17We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Insecticides (India) Limited's (NSE:INSECTICID) CEO For NowKey Insights Insecticides (India) will host its Annual General Meeting on 23rd of September Total pay for CEO Rajesh...
お知らせ • Sep 02+ 1 more updateInsecticides (India) Limited to Report Q3, 2024 Results on Feb 14, 2024Insecticides (India) Limited announced that they will report Q3, 2024 results on Feb 14, 2024
お知らせ • Aug 11Insecticides (India) Limited, Annual General Meeting, Sep 23, 2023Insecticides (India) Limited, Annual General Meeting, Sep 23, 2023, at 15:00 Indian Standard Time.
Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹9.85 (vs ₹12.94 in 1Q 2023)First quarter 2024 results: EPS: ₹9.85 (down from ₹12.94 in 1Q 2023). Revenue: ₹6.44b (up 15% from 1Q 2023). Net income: ₹291.4m (down 24% from 1Q 2023). Profit margin: 4.5% (down from 6.8% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Aug 05These 4 Measures Indicate That Insecticides (India) (NSE:INSECTICID) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹21.36 (vs ₹36.11 in FY 2022)Full year 2023 results: EPS: ₹21.36 (down from ₹36.11 in FY 2022). Revenue: ₹18.0b (up 20% from FY 2022). Net income: ₹632.1m (down 41% from FY 2022). Profit margin: 3.5% (down from 7.1% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.
Buying Opportunity • May 31Now 23% undervaluedOver the last 90 days, the stock is up 5.0%. The fair value is estimated to be ₹580, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.8% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 26% in 2 years. Earnings is forecast to grow by 45% in the next 2 years.
Price Target Changed • Mar 21Price target decreased by 8.2% to ₹681Down from ₹742, the current price target is an average from 3 analysts. New target price is 43% above last closing price of ₹477. Stock is up 14% over the past year. The company posted earnings per share of ₹36.11 last year.
分析記事 • Feb 25Here's Why Insecticides (India) (NSE:INSECTICID) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹470, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 63% over the past three years.
Upcoming Dividend • Feb 17Upcoming dividend of ₹3.00 per share at 0.5% yieldEligible shareholders must have bought the stock before 24 February 2023. Payment date: 15 March 2023. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.6%). Lower than average of industry peers (0.8%).
お知らせ • Feb 14Insecticides (India) Limited Declares an Interim Dividend for Financial Year 2022-2023, Payable on February 24, 2023Insecticides (India) Limited announced that at the board meeting held on February 13, 2023, the company declared an interim dividend of INR 3.00 per equity shares [30%] of face value of INR 10/- each for financial year 2022-2023. The record date as informed for the purpose of determining for entitlement of the shareholders for the payment of Interim Dividend is 24 day of February, 2023 and the Interim Dividend will be paid to the shareholders, subject to deduction/withholding of applicable taxes, within the time prescribed under law.
Reported Earnings • Feb 14Third quarter 2023 earnings released: EPS: ₹3.16 (vs ₹2.79 in 3Q 2022)Third quarter 2023 results: EPS: ₹3.16 (up from ₹2.79 in 3Q 2022). Revenue: ₹3.57b (up 14% from 3Q 2022). Net income: ₹93.7m (up 14% from 3Q 2022). Profit margin: 2.6% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Jan 06Price target increased to ₹742Up from ₹676, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹727. Stock is up 52% over the past year. The company posted earnings per share of ₹36.11 last year.
Reported Earnings • Nov 09Second quarter 2023 earnings released: EPS: ₹15.15 (vs ₹14.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹15.15 (up from ₹14.15 in 2Q 2022). Net income: ₹448.3m (up 7.1% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Sep 17We Think Some Shareholders May Hesitate To Increase Insecticides (India) Limited's (NSE:INSECTICID) CEO CompensationThe share price of Insecticides (India) Limited ( NSE:INSECTICID ) has increased significantly over the past few years...
Upcoming Dividend • Sep 08Upcoming dividend of ₹3.00 per shareEligible shareholders must have bought the stock before 15 September 2022. Payment date: 23 October 2022. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.6%). Lower than average of industry peers (0.7%).
お知らせ • Sep 03+ 1 more updateInsecticides (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Insecticides (India) Limited announced that they will report Q3, 2023 results on Feb 14, 2023
Price Target Changed • Aug 18Price target increased to ₹925Up from ₹807, the current price target is provided by 1 analyst. New target price is 9.2% below last closing price of ₹1,019. Stock is up 35% over the past year. The company posted earnings per share of ₹54.17 last year.
Reported Earnings • Aug 14First quarter 2023 earnings released: EPS: ₹19.41 (vs ₹17.37 in 1Q 2022)First quarter 2023 results: EPS: ₹19.41 (up from ₹17.37 in 1Q 2022). Revenue: ₹5.61b (up 20% from 1Q 2022). Net income: ₹383.1m (up 9.6% from 1Q 2022). Profit margin: 6.8% (down from 7.5% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Price Target Changed • Jun 02Price target increased to ₹803Up from ₹748, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of ₹788. Stock is up 43% over the past year. The company posted earnings per share of ₹54.17 last year.
Reported Earnings • May 27Full year 2022 earnings released: EPS: ₹54.17 (vs ₹45.43 in FY 2021)Full year 2022 results: EPS: ₹54.17 (up from ₹45.43 in FY 2021). Revenue: ₹15.1b (up 6.2% from FY 2021). Net income: ₹1.07b (up 14% from FY 2021). Profit margin: 7.1% (up from 6.6% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. Independent Non-Executive Women Director Praveen Gupta was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹4.18 (up from ₹2.97 in 3Q 2021). Revenue: ₹3.14b (up 4.9% from 3Q 2021). Net income: ₹82.6m (up 34% from 3Q 2021). Profit margin: 2.6% (up from 2.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 13Second quarter 2022 earnings released: EPS ₹21.22 (vs ₹20.13 in 2Q 2021)The company reported a mediocre second quarter result with weaker revenues, although earnings were flat and profit margins improved. Second quarter 2022 results: Revenue: ₹4.44b (down 2.7% from 2Q 2021). Net income: ₹418.8m (flat on 2Q 2021). Profit margin: 9.4% (up from 9.1% in 2Q 2021). The increase in margin was driven by lower expenses.
Reported Earnings • Aug 11First quarter 2022 earnings released: EPS ₹17.37 (vs ₹11.79 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹4.68b (up 14% from 1Q 2021). Net income: ₹349.6m (up 44% from 1Q 2021). Profit margin: 7.5% (up from 5.9% in 1Q 2021). The increase in margin was driven by higher revenue.
分析記事 • Aug 04Does Insecticides (India) (NSE:INSECTICID) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Jun 20Full year 2021 earnings released: EPS ₹45.43 (vs ₹42.05 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹14.3b (up 4.7% from FY 2020). Net income: ₹939.0m (up 8.0% from FY 2020). Profit margin: 6.6% (up from 6.4% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹639, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 9.1% over the past three years.
分析記事 • May 25The Returns On Capital At Insecticides (India) (NSE:INSECTICID) Don't Inspire ConfidenceIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
分析記事 • May 04Here's What You Should Know About Insecticides (India) Limited's (NSE:INSECTICID) 0.4% Dividend YieldCould Insecticides (India) Limited ( NSE:INSECTICID ) be an attractive dividend share to own for the long haul...
Price Target Changed • Apr 10Price target decreased to ₹529Down from ₹574, the current price target is provided by 1 analyst. New target price is 13% above last closing price of ₹468. Stock is up 35% over the past year.
Is New 90 Day High Low • Mar 15New 90-day low: ₹446The company is down 5.0% from a price of ₹470 on 15 December 2020. Underperformed the Indian market, which is up 14% over the last 90 days. Lagged the Chemicals industry, which is up 9.0% over the same period.
分析記事 • Mar 10We Think Insecticides (India) (NSE:INSECTICID) Can Stay On Top Of Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Feb 23The Trends At Insecticides (India) (NSE:INSECTICID) That You Should Know AboutIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
分析記事 • Feb 10If You Had Bought Insecticides (India) (NSE:INSECTICID) Shares Five Years Ago You'd Have Earned 54% ReturnsThe main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...
Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹2.97 (vs ₹4.30 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹3.00b (up 14% from 3Q 2020). Net income: ₹61.5m (down 31% from 3Q 2020). Profit margin: 2.0% (down from 3.4% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 17% per year.
Is New 90 Day High Low • Feb 04New 90-day high: ₹511The company is up 11% from its price of ₹460 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
分析記事 • Jan 28Read This Before Buying Insecticides (India) Limited (NSE:INSECTICID) For Its DividendCould Insecticides (India) Limited ( NSE:INSECTICID ) be an attractive dividend share to own for the long haul...
Is New 90 Day High Low • Jan 15New 90-day high: ₹510The company is up 7.0% from its price of ₹478 on 16 October 2020. The Indian market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period.
分析記事 • Jan 13Here's What Insecticides (India) Limited's (NSE:INSECTICID) Shareholder Ownership Structure Looks LikeA look at the shareholders of Insecticides (India) Limited ( NSE:INSECTICID ) can tell us which group is most powerful...
分析記事 • Dec 29Insecticides (India) Limited's (NSE:INSECTICID) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?With its stock down 4.9% over the past three months, it is easy to disregard Insecticides (India) (NSE:INSECTICID...
分析記事 • Dec 14Here's Why We Think Insecticides (India)'s (NSE:INSECTICID) Statutory Earnings Might Be ConservativeStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. However...
分析記事 • Nov 29These 4 Measures Indicate That Insecticides (India) (NSE:INSECTICID) Is Using Debt Reasonably WellDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Nov 14Should You Buy Insecticides (India) Limited (NSE:INSECTICID) For Its Upcoming Dividend?Readers hoping to buy Insecticides (India) Limited (NSE:INSECTICID) for its dividend will need to make their move...
Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS ₹20.13The company reported a poor second quarter result with weaker earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₹4.61b (down 8.4% from 2Q 2020). Net income: ₹416.1m (down 15% from 2Q 2020). Profit margin: 9.0% (in line with 2Q 2020).
Is New 90 Day High Low • Nov 10New 90-day low: ₹445The company is down 6.0% from its price of ₹475 on 12 August 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
分析記事 • Nov 09Insecticides (India)'s (NSE:INSECTICID) Stock Price Has Reduced 46% In The Past Three YearsMany investors define successful investing as beating the market average over the long term. But its virtually certain...
分析記事 • Oct 19Returns On Capital At Insecticides (India) (NSE:INSECTICID) Paint An Interesting PictureIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
